Crossmark

Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya

Crossref DOI link: https://doi.org/10.1186/s12936-020-03505-0

Published Online: 2020-11-25

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hill, Jenny https://orcid.org/0000-0003-1588-485X
Ouma, Peter

Oluoch, Seth

Bruce, Jane

Kariuki, Simon

Desai, Meghna

Webster, Jayne
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation (OPP46099)
License Information

Text and Data Mining valid from 2020-11-25

Version of Record valid from 2020-11-25
More Information

Article History

Received: 2 July 2020

Accepted: 17 November 2020

First Online: 25 November 2020

Competing interests

: The authors have no competing interests.

Document is current

Any future updates will be listed below